Page 12 - Pharma
Gene therapy to conquering hepatitis C: A decade of medical breakthroughs
Putting aside prices for a moment, it's been an exciting period for medical progress
 "Gene therapy to conquering hepatitis C: A decade of medical breakthroughs")
NITI Aayog plans to bring all medical devices under one regulatory regime
The NITI Aayog has proposed to do away with the need to have manufacturing licences to register a medical device
 "NITI Aayog plans to bring all medical devices under one regulatory regime")
Pharma sector likely to grow at 10-12% during FY19-22, outlook stable: Icra
Icra cited abating headwinds from pricing pressure in the US, stable growth for the Indian market driven by increasing healthcare spending
Price hike, at last
Govt should not control drug prices
 "Price hike, at last")
Ceiling prices of 21 key medicines raised by 50%; NPPA invokes DPCO 2013
The prices of APIs have gone up in the range of 5-88%
 "Ceiling prices of 21 key medicines raised by 50%; NPPA invokes DPCO 2013")
Stricter regulations, pricing control slow down pharma sector growth
The fifth part of the series looks at what's ailing the pharma sector
 "Stricter regulations, pricing control slow down pharma sector growth")
Aurobindo recalls heartburn drug ranitidine, two others from US market
Development follows regulatory compliance issues being faced by several of its plants back home; Ranitidine taken off due to the presence of carcinogenic compound
Dr Reddy's launches cancer treatment drug Bortezomib in the US market
Bortezomib is an active ingredient similar to that of the once blockbuster cancer treatment Velcade of Millennium Pharmaceuticals
 "Dr Reddy's launches cancer treatment drug Bortezomib in the US market")
MedLife's secret sauce behind delivering medicines in less than 2 hours
MedLife has mobile apps for everyone, and a smartphone is where all the tasks happen
 "MedLife's secret sauce behind delivering medicines in less than 2 hours")
Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts
Big entities such as Aurobindo and Dr Reddy's have been currently filing for new product approvals from multiple sites
 "Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts")
Develop entire value chain: Dr Reddy's MD tells pharma companies
US-China trade war is going to give us a window of opportunity to expand our industry, says G V Prasad
 "Develop entire value chain: Dr Reddy's MD tells pharma companies")
GPAT 2020 registration process begins: Know important dates, steps to apply
GPAT is a national-level entrance examination for admission to MPharma programmes
Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival
Analysts expect a 12% growth in revenues for the sector
 "Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival")
Pharma Monday blues: USFDA warnings drag down Glenmark, Aurobindo stocks
The Nifty Pharma index fell 3.35 per cent during the day.
Pharma PSUs likely to sign MoU with LMA for sale of surplus land
The PSUs thus are hopeful that the sale process could now be expedited
 "Pharma PSUs likely to sign MoU with LMA for sale of surplus land")
We are growing our biosimilars capacity six-fold: Lupin MD Nilesh D Gupta
We were into APIs in the US and we started finished products, said Nilesh D Gupta
 "We are growing our biosimilars capacity six-fold: Lupin MD Nilesh D Gupta")
Pfizer clears the decks for fresh start, looks to energise bestseller list
With six big brands that never hit the high notes in India, bundled into its venture with Mylan, the pharma major looks to energise its bestseller list
 "Pfizer clears the decks for fresh start, looks to energise bestseller list")
India seeks 'clear roadmap' from China to ramp up export of pharma products
Besides pharmaceuticals, India has been asking China to open up its IT market as well to ensure steady increase of Indian exports
 "India seeks 'clear roadmap' from China to ramp up export of pharma products")
Indian pharma industry likely to grow by 11% to $41.9 bn in FY20: Report
The industry is expected to grow at around 12 per cent and reach $20.4-$20.8 billion in the domestic market
 "Indian pharma industry likely to grow by 11% to $41.9 bn in FY20: Report")
Pharma's share in greenhouse emissions more than automotive sector: Study
More than 200 companies represent the global pharmaceutical market, yet only 25 consistently reported their direct and indirect greenhouse gas emissions in the past five years
 "Pharma's share in greenhouse emissions more than automotive sector: Study")